Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing oral fluconazole with oral itraconazole for resistant tinea corporis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluconazole (Fluconazole)
  • Itraconazole (Itraconazole)

Snippet

Sponsor: Urooj Fatima | Conditions: Tinea Corporis, Dermatophytosis | Phase 4 | Status: RECRUITING